Thomas A. Davis

5.2k total citations · 1 hit paper
73 papers, 3.1k citations indexed

About

Thomas A. Davis is a scholar working on Rheumatology, Genetics and Molecular Biology. According to data from OpenAlex, Thomas A. Davis has authored 73 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 18 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Thomas A. Davis's work include Heterotopic Ossification and Related Conditions (23 papers), Parathyroid Disorders and Treatments (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Thomas A. Davis is often cited by papers focused on Heterotopic Ossification and Related Conditions (23 papers), Parathyroid Disorders and Treatments (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Thomas A. Davis collaborates with scholars based in United States, United Kingdom and Australia. Thomas A. Davis's co-authors include Khairul Anam, Eric A. Elster, Benjamin Lévi, Mihret F. Amare, Allen R. Braun, Michael R. Landauer, Regina M. Day, Thomas N. Chase, Paolo Barone and David Cholok and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Thomas A. Davis

72 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

2015 313 citations Scott Cruickshank, Tibor Keler et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas A. Davis United States	30	760	760	721	613	546	73	3.1k
Jun‐ichi Kuratsu Japan	40	1.1k 1.5×	679 0.9×	496 0.7×	1.5k 2.4×	584 1.1×	200	5.6k
Christian Hagel Germany	36	1.1k 1.5×	381 0.5×	417 0.6×	707 1.2×	371 0.7×	202	4.0k
Marieke J. H. Coenen Netherlands	34	1.1k 1.4×	369 0.5×	718 1.0×	249 0.4×	272 0.5×	131	3.2k
Anne E. Hughes United Kingdom	26	1.0k 1.3×	574 0.8×	371 0.5×	151 0.2×	529 1.0×	59	3.0k
Masafumi Ito Japan	31	1.2k 1.6×	575 0.8×	310 0.4×	590 1.0×	112 0.2×	175	3.9k
Libero Lauriola Italy	39	1.1k 1.4×	637 0.8×	167 0.2×	991 1.6×	239 0.4×	179	4.3k
Anthony Béhin France	33	1.6k 2.1×	365 0.5×	365 0.5×	773 1.3×	201 0.4×	145	3.9k
Ho Jin Kim South Korea	41	654 0.9×	569 0.7×	1.3k 1.9×	275 0.4×	330 0.6×	172	5.9k
P. Martin van Hagen Netherlands	37	705 0.9×	594 0.8×	381 0.5×	121 0.2×	538 1.0×	134	3.6k
Paolo A. Muraro United Kingdom	41	803 1.1×	1.4k 1.9×	849 1.2×	474 0.8×	283 0.5×	128	5.9k

Countries citing papers authored by Thomas A. Davis

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Davis more than expected).

Fields of papers citing papers by Thomas A. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Davis. The network helps show where Thomas A. Davis may publish in the future.

Co-authorship network of co-authors of Thomas A. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Davis. A scholar is included among the top collaborators of Thomas A. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Davis. Thomas A. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salinas, Daniela, et al.. (2023). Inhibition of focal adhesion kinase 2 results in a macrophage polarization shift to M2 which attenuates local and systemic inflammation and reduces heterotopic ossification after polysystem extremity trauma. Frontiers in Immunology. 14. 1280884–1280884. 5 indexed citations

Strong, Amy L., Philip Spreadborough, Devaveena Dey, et al.. (2020). BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma. Stem Cells and Development. 30(2). 91–105. 24 indexed citations

Martin, Elizabeth C., Claire B. Llamas, Ammar T. Qureshi, et al.. (2020). Proteomic characterization of a trauma-based rat model of heterotopic ossification identifies interactive signaling networks as potential therapeutic targets. Journal of Proteomics. 226. 103907–103907. 1 indexed citations

Cholok, David, Michael T. Chung, Kavitha Ranganathan, et al.. (2017). Heterotopic ossification and the elucidation of pathologic differentiation. Bone. 109. 12–21. 58 indexed citations

Qureshi, Ammar T., Devaveena Dey, B. M. Wheatley, et al.. (2017). Inhibition of Mammalian Target of Rapamycin Signaling with Rapamycin Prevents Trauma-Induced Heterotopic Ossification. American Journal Of Pathology. 187(11). 2536–2545. 44 indexed citations

Burris, Howard A., Jeffrey R. Infante, Stephen M. Ansell, et al.. (2017). Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 35(18). 2028–2036. 108 indexed citations

Cholok, David, Eric Lee, Jeffrey Lisiecki, et al.. (2016). Traumatic muscle fibrosis. The Journal of Trauma: Injury, Infection, and Critical Care. 82(1). 174–184. 25 indexed citations

Agarwal, Shailesh, Shawn Loder, Cameron Brownley, et al.. (2015). Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification. Proceedings of the National Academy of Sciences. 113(3). E338–47. 172 indexed citations

Yardley, Denise A., Robert Weaver, Michelle Melisko, et al.. (2015). EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer. Journal of Clinical Oncology. 33(14). 1609–1619. 145 indexed citations

10.

Ranganathan, Kavitha, Jonathan Peterson, Shailesh Agarwal, et al.. (2015). Role of Gender in Burn-Induced Heterotopic Ossification and Mesenchymal Cell Osteogenic Differentiation. Plastic & Reconstructive Surgery. 135(6). 1631–1641. 36 indexed citations

11.

Davis, Thomas A., Michael R. Landauer, Steven Mog, et al.. (2011). Response to Moulder et al., “Re: Davis et al., ‘Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation’”. Experimental Hematology. 39(5). 522–524. 1 indexed citations

12.

Amare, Mihret F., et al.. (2010). Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy. Angiogenesis. 13(4). 293–304. 44 indexed citations

13.

Barshishat-Küpper, Michal, Ognoon Mungunsukh, Ashlee J. Tipton, et al.. (2010). Captopril modulates hypoxia-inducible factors and erythropoietin responses in a murine model of total body irradiation. Experimental Hematology. 39(3). 293–304. 31 indexed citations

14.

Davis, Thomas A., Michael R. Landauer, Steven Mog, et al.. (2010). Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Experimental Hematology. 38(4). 270–281. 57 indexed citations

15.

Davis, Thomas A., Alexander Stojadinovic, Khairul Anam, et al.. (2008). Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury*. International Wound Journal. 6(1). 11–21. 115 indexed citations

16.

Davis, Thomas A., et al.. (2008). Genistein induces radioprotection by hematopoietic stem cell quiescence. International Journal of Radiation Biology. 84(9). 713–726. 74 indexed citations

17.

Chute, John P., et al.. (1996). Aplastic anemia as the sole presentation of systemic lupus erythematosus. American Journal of Hematology. 51(3). 237–239. 1 indexed citations

18.

Chute, John P., et al.. (1996). Aplastic anemia as the sole presentation of systemic lupus erythematosus. American Journal of Hematology. 51(3). 237–239. 7 indexed citations

19.

Monroy, Rodney L., R R Skelly, Thomas A. Davis, & Thomas J. MacVittie. (1992). Therapeutic evaluation of interleukin-1 for stimulation of hematopoiesis in primates after autologous bone marrow transplantation. Biotherapy. 4(2). 97–108. 12 indexed citations

20.

Monroy, Rodney L., Thomas A. Davis, & Thomas J. MacVittie. (1990). Granulocyte-macrophage colony-stimulating factor: More than a hemopoietin. Clinical Immunology and Immunopathology. 54(3). 333–346. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact